Home page of finance and economics  |  Sina homepage  |  Sina Navigation
Feedback Selected stock pool Home page of finance and economics shares fund Hong Kong shares US stocks futures foreign exchange noble metal bond Market Individual shares New shares data live broadcast Blog Stock exchange Optional shares
Sina Finance > Market center > Boji Medicine > quotation
Recently visited unit
Optional shares
name Price (yuan) Rise and fall
The following are popular stocks
Please check the self selected shares first
join remind View in APP

Boji Medicine (300404.SZ)

Questioning stocks
@change@
@changeP@
@now@
Limit: @ up_limit@
Limit: @ down_limit@
Suspension
@date@ @time@
Temporary suspension
Today: @open@ Volume: @volume@ Amplitude: @swing@
Maximum: @high@ Turnover: @amount@ turnover rate: @turnover@
Minimum: @low@ Total Market Value: @fixTotalShare@ P/B ratio: @pb@
Received yesterday: @preClose@ Circulation value: @cvs@ P/E ratio TTM ： @pe@
Total share capital: @zgb@ Circulating shares: @ltgb@
Information mine:
    The browser version is too low to view the multi null inversion

    Your browser version is too low to view empty data. It is recommended to use IE10 (including) above Firefox 、 Google

    Time-sharing
    Day K
    Week K
    Month K
    K line
    Reinstatement K line
    Technical drawings
    Also concerned:
      5th gear disc opening
      Live broadcast of famous teachers
      Commission ratio -- Abandonment --
      Selling ⑤ -- --
      Sell ④ -- --
      Selling ③ -- --
      Sell ② -- --
      Selling ① -- --
      deal --
      Buy ① -- --
      Buy ② -- --
      Buy ③ -- --
      Buy ④ -- --
      Buy ⑤ -- --
      Outer disc -- Inner disc --

      In case of a key big order, the main force may**

      Quickly use level2 to view details>
      Pen by pen
      Time-sharing
      time Price (yuan) Measurement (hand) nature
      time Price (yuan) Measurement (hand) nature
      Transaction price (yuan) Trading volume (hand) Proportion (%)
      time Transaction price (yuan) Trading volume (hand)
      Product entry: Sina Finance APP - Stocks - Investment Research Report
      Product entrance: Sina Finance APP - stock - free question
      Product entrance: Sina Finance APP - stock - free question

      money flow

      Main compass Indicator description
      Main and retail investors' capital flow
      Main buy Main sales Purchase by retail investors Retail sales
      Amount (10000 yuan) @mainIn@ @mainOut@ @retailIn@ @retailOut@
      proportion @mainInP@ @mainOutP@ @retailInP@ @retailOutP@
      Loose bill
      Small order
      Large order
      Extra large order
      Net inflow of classified funds
      Loose bill Small order Large order Extra large order
      Net inflow (10000 yuan) @r3_r_in@ @r2_r_in@ @r1_r_in@ @r0_r_in@
      Proportion in the flow board @r3_p_svs@ @r2_p_svs@ @r1_p_svs@ @r0_p_svs@
      Proportion in turnover rate @r3_p_turnover@ @r2_p_turnover@ @r1_p_turnover@ @r0_p_turnover@
      more

      Company Information

      more

      research report

      Company research
      Industry research
      more Post

      Boji Pharmaceutical Stock Exchange

      title click reply Final reply

      Company research

      Hot data

      more
      Adjacent ranking
      Top 10 in the industry

      Financial ratios

      more
      Adjacent ranking
      Top 10 in the industry

      Investment rating of research institutions

      more

      In the last 60 days Boji Pharmaceutical (sz300404) rating was released in three research reports, and the comprehensive rating is as follows:

      Hot columns

      Industry comparison

      name Price (yuan)
      more

      Company Profile

      corporate name:

      Boji Pharmaceutical Technology Co., Ltd

      Main business:

      Provide preclinical research services, clinical research and development of new drugs for pharmaceutical enterprises and other new drug research and development institutions

      Telephone: 020-35647628,020-38473208

      Fax: 020-35647628

      Date of establishment: 2002-09-29

      Listing date: 2015-04-24

      Legal representative: Wang Tingchun

      general manager: Wang Tingchun

      Registered capital: 382.207 million yuan

      Issue price: 12.870 yuan

      Latest total share capital: 382207238 shares

      Latest outstanding shares: 275570812 shares

      Segment: GEM Shenzhen A-share Shanghai and Shenzhen A-share Shenzhen Composite Index medical apparatus and instruments CRO concept CXO concept Innovative medicine Pharmaceutical Biology medical service Pharmaceutical Biology Medical R&D outsourcing

      more

      Financial summary

      2024-03
      2023-12
      2023-09
      2023-06
      2023-03
      Earnings per share 0.0432 yuan 0.0637 yuan 0.0622 yuan 0.0476 yuan 0.0318 yuan
      net asset value per share 2.5103 yuan 2.5023 yuan 2.3980 yuan 2.3893 yuan 2.3594 yuan
      Net operating cash flow per share -0.0413 yuan 0.0941 yuan -0.0068 yuan -0.0200 yuan -0.0001 yuan
      Return on net assets 1.72% 2.55% 2.59% 1.99% 1.35%
      Undistributed profit per share RMB 0.5315 0.4883 yuan RMB 0.5047 RMB 0.5002 0.4860 yuan
      Capital reserve per share 0.9494 yuan 0.9465 yuan 0.8268 yuan 0.8212 yuan 0.7990 yuan
      more

      Dividend distribution

      Date of announcement Allocation scheme
      2024-05-18 10 pairs 0.1 yuan
      2023-07-04 10 pairs 0.1 yuan
      2022-05-26 10 RMB 0.2 to 4 shares
      2020-06-05 10 yuan to 3 shares
      2019-05-31 10 RMB 0.15 to 3 shares
      more

      Circulation shareholders

      2024-03
      2024-02
      2023-12
      Name of shareholders Shareholding (%) Increase or decrease
      Wang Tingchun ten point seven seven four Unchanged
      Chai Changmao four point two eight one Unchanged
      Hengqin Guangjin Meihao Foundation three point three eight nine Unchanged
      Zhao Yulan two point one two six Overweight
      Zhao Lingli one point nine one seven Unchanged
      Cui Xiuhua one point zero one four Overweight
      Gongqing City Yinyi Investment zero point nine six six Unchanged
      Gongqing City Yinchi Investment zero point nine three two Unchanged
      Ma Renqiang zero point seven two seven New progress
      Li Ze zero point seven two six New progress

      Shareholding ratio of circulating shareholders

      Sina Finance provides free stock, fund, bond, foreign exchange and other market data as well as other information from relevant partners, which is only for the purpose of obtaining information for users and does not constitute investment advice.
      Sina Finance and its partners will not be responsible for the error, deformity, delay of the information provided on this page or any action taken by relying on this information. There are risks in the market, so investment should be cautious.


      user name:
      Password: